NCT00909311View on ClinicalTrials.gov

Study in Healthy Adults to Evaluate Effect of Food on Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir

PHASE1CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

July 31, 2009

Conditions
HCV Infection
Interventions
DRUG

ABT-450

capsules, QD, 1 dose in each cross-over period

DRUG

ritonavir

capsule, QD, 1 dose in each cross-over period

Trial Locations (1)

60085

Site Reference ID/Investigator# 19421, Waukegan

Sponsors

Lead Sponsor

Abbott
All Listed Sponsors
lead

Abbott

INDUSTRY

NCT00909311 - Study in Healthy Adults to Evaluate Effect of Food on Pharmacokinetics, Safety and Tolerability of ABT-450 With Ritonavir | Biotech Hunter | Biotech Hunter